A Randomized, placebo-controlled crossover study to evaluate postprandial glucometabolic effects of mulberry leaf extract, vitamin D, chromium, and fiber in people with type 2 diabetes

Introduction: Reducing postprandial (PP) hyperglycemia and PP glucose excursions is important for overall glycemic management. Although most therapeutic lifestyle interventions that reduce caloric intake would affect this, there is no particular nutritional intervention favored. Methods: We evaluate...

Full description

Bibliographic Details
Main Authors: Mohamed, Mafauzy, Zagury, Roberto Luis, Bhaskaran, Kalpana, Neutel, Joel, Mohd Yusof, Barakatun Nisak, Mooney, Linda, Yeo, Lihe, Kirwan, Bridget-Anne, Aprikian, Olivier, von Eynatten, Maximilian, Johansen, Odd Erik
Format: Article
Published: Springer Healthcare 2023
_version_ 1825939390780669952
author Mohamed, Mafauzy
Zagury, Roberto Luis
Bhaskaran, Kalpana
Neutel, Joel
Mohd Yusof, Barakatun Nisak
Mooney, Linda
Yeo, Lihe
Kirwan, Bridget-Anne
Aprikian, Olivier
von Eynatten, Maximilian
Johansen, Odd Erik
author_facet Mohamed, Mafauzy
Zagury, Roberto Luis
Bhaskaran, Kalpana
Neutel, Joel
Mohd Yusof, Barakatun Nisak
Mooney, Linda
Yeo, Lihe
Kirwan, Bridget-Anne
Aprikian, Olivier
von Eynatten, Maximilian
Johansen, Odd Erik
author_sort Mohamed, Mafauzy
collection UPM
description Introduction: Reducing postprandial (PP) hyperglycemia and PP glucose excursions is important for overall glycemic management. Although most therapeutic lifestyle interventions that reduce caloric intake would affect this, there is no particular nutritional intervention favored. Methods: We evaluated the effects of a novel natural food adjuvant combining mulberry leaf extract (MLE) with other bioactive ingredients, in people with type 2 diabetes (T2D) originating from Asia, on improving PP glucometabolic response in a randomized controlled exploratory crossover, two-center study (USA, Singapore). A 2-g blend of 250 mg MLE containing 12.5 mg of 1-deoxynojirimycin (DNJ), fiber (1.75 g), vitamin D3 (0.75 ¼g), and chromium (75 ¼g), compared with a similar blend without the MLE, was sprinkled over a 350-kcal breakfast meal (55.4 g carbs) and PP blood glucose (primary exploratory endpoint), insulin, and incretin hormones (GLP-1, GIP) were evaluated in blood samples over 3 h. Changes in incremental areas under the concentration curve (iAUC) and maximum concentrations (Cmax) were compared. Results: Thirty individuals (12 women, mean age 59 years, HbA1c 7.1%, BMI 26.5 kg/m2) were enrolled and the MLE-based blend relative to the blend without MLE significantly reduced glucose iAUC at 1 h (ˆ’ 20%, p < 0.0001), 2 h (ˆ’ 17%, p = 0.0001), and 3 h (ˆ’ 15%, p = 0.0032) and Cmax mean (95% CI) difference ˆ’ 0.8 (ˆ’ 1.2, ˆ’ 0.3) mmol/L, p = 0.0006. A statistically significant reduction in 1 h insulin iAUC (ˆ’ 24%, p = 0.0236) was observed, but this reduction was no longer present at either 2 h or 3 h. No difference in GLP-1 was seen, but GIP response (iAUC and Cmax) was less with the MLE-based blend. Conclusions: The observation of a significant glucose reduction paralleled with a significant lower insulin response supports a reduced gastrointestinal glucose absorption. These results support the use of a 2-g natural blend of MLE, fiber, vitamin D, and chromium in T2D as a convenient dietary adjuvant to improve PP glucometabolic response. ClinicalTrials.gov identifier NCT04877366.
first_indexed 2024-12-09T02:17:47Z
format Article
id upm.eprints-106660
institution Universiti Putra Malaysia
last_indexed 2024-12-09T02:17:47Z
publishDate 2023
publisher Springer Healthcare
record_format dspace
spelling upm.eprints-1066602024-09-26T08:25:40Z http://psasir.upm.edu.my/id/eprint/106660/ A Randomized, placebo-controlled crossover study to evaluate postprandial glucometabolic effects of mulberry leaf extract, vitamin D, chromium, and fiber in people with type 2 diabetes Mohamed, Mafauzy Zagury, Roberto Luis Bhaskaran, Kalpana Neutel, Joel Mohd Yusof, Barakatun Nisak Mooney, Linda Yeo, Lihe Kirwan, Bridget-Anne Aprikian, Olivier von Eynatten, Maximilian Johansen, Odd Erik Introduction: Reducing postprandial (PP) hyperglycemia and PP glucose excursions is important for overall glycemic management. Although most therapeutic lifestyle interventions that reduce caloric intake would affect this, there is no particular nutritional intervention favored. Methods: We evaluated the effects of a novel natural food adjuvant combining mulberry leaf extract (MLE) with other bioactive ingredients, in people with type 2 diabetes (T2D) originating from Asia, on improving PP glucometabolic response in a randomized controlled exploratory crossover, two-center study (USA, Singapore). A 2-g blend of 250 mg MLE containing 12.5 mg of 1-deoxynojirimycin (DNJ), fiber (1.75 g), vitamin D3 (0.75 ¼g), and chromium (75 ¼g), compared with a similar blend without the MLE, was sprinkled over a 350-kcal breakfast meal (55.4 g carbs) and PP blood glucose (primary exploratory endpoint), insulin, and incretin hormones (GLP-1, GIP) were evaluated in blood samples over 3 h. Changes in incremental areas under the concentration curve (iAUC) and maximum concentrations (Cmax) were compared. Results: Thirty individuals (12 women, mean age 59 years, HbA1c 7.1%, BMI 26.5 kg/m2) were enrolled and the MLE-based blend relative to the blend without MLE significantly reduced glucose iAUC at 1 h (ˆ’ 20%, p < 0.0001), 2 h (ˆ’ 17%, p = 0.0001), and 3 h (ˆ’ 15%, p = 0.0032) and Cmax mean (95% CI) difference ˆ’ 0.8 (ˆ’ 1.2, ˆ’ 0.3) mmol/L, p = 0.0006. A statistically significant reduction in 1 h insulin iAUC (ˆ’ 24%, p = 0.0236) was observed, but this reduction was no longer present at either 2 h or 3 h. No difference in GLP-1 was seen, but GIP response (iAUC and Cmax) was less with the MLE-based blend. Conclusions: The observation of a significant glucose reduction paralleled with a significant lower insulin response supports a reduced gastrointestinal glucose absorption. These results support the use of a 2-g natural blend of MLE, fiber, vitamin D, and chromium in T2D as a convenient dietary adjuvant to improve PP glucometabolic response. ClinicalTrials.gov identifier NCT04877366. Springer Healthcare 2023-03-01 Article PeerReviewed Mohamed, Mafauzy and Zagury, Roberto Luis and Bhaskaran, Kalpana and Neutel, Joel and Mohd Yusof, Barakatun Nisak and Mooney, Linda and Yeo, Lihe and Kirwan, Bridget-Anne and Aprikian, Olivier and von Eynatten, Maximilian and Johansen, Odd Erik (2023) A Randomized, placebo-controlled crossover study to evaluate postprandial glucometabolic effects of mulberry leaf extract, vitamin D, chromium, and fiber in people with type 2 diabetes. Diabetes Therapy, 14 (4). pp. 749-766. ISSN 1869-6953; ESSN: 1869-6961 https://link.springer.com/article/10.1007/s13300-023-01379-4 10.1007/s13300-023-01379-4
spellingShingle Mohamed, Mafauzy
Zagury, Roberto Luis
Bhaskaran, Kalpana
Neutel, Joel
Mohd Yusof, Barakatun Nisak
Mooney, Linda
Yeo, Lihe
Kirwan, Bridget-Anne
Aprikian, Olivier
von Eynatten, Maximilian
Johansen, Odd Erik
A Randomized, placebo-controlled crossover study to evaluate postprandial glucometabolic effects of mulberry leaf extract, vitamin D, chromium, and fiber in people with type 2 diabetes
title A Randomized, placebo-controlled crossover study to evaluate postprandial glucometabolic effects of mulberry leaf extract, vitamin D, chromium, and fiber in people with type 2 diabetes
title_full A Randomized, placebo-controlled crossover study to evaluate postprandial glucometabolic effects of mulberry leaf extract, vitamin D, chromium, and fiber in people with type 2 diabetes
title_fullStr A Randomized, placebo-controlled crossover study to evaluate postprandial glucometabolic effects of mulberry leaf extract, vitamin D, chromium, and fiber in people with type 2 diabetes
title_full_unstemmed A Randomized, placebo-controlled crossover study to evaluate postprandial glucometabolic effects of mulberry leaf extract, vitamin D, chromium, and fiber in people with type 2 diabetes
title_short A Randomized, placebo-controlled crossover study to evaluate postprandial glucometabolic effects of mulberry leaf extract, vitamin D, chromium, and fiber in people with type 2 diabetes
title_sort randomized placebo controlled crossover study to evaluate postprandial glucometabolic effects of mulberry leaf extract vitamin d chromium and fiber in people with type 2 diabetes
work_keys_str_mv AT mohamedmafauzy arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT zaguryrobertoluis arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT bhaskarankalpana arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT neuteljoel arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT mohdyusofbarakatunnisak arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT mooneylinda arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT yeolihe arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT kirwanbridgetanne arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT aprikianolivier arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT voneynattenmaximilian arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT johansenodderik arandomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT mohamedmafauzy randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT zaguryrobertoluis randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT bhaskarankalpana randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT neuteljoel randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT mohdyusofbarakatunnisak randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT mooneylinda randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT yeolihe randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT kirwanbridgetanne randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT aprikianolivier randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT voneynattenmaximilian randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes
AT johansenodderik randomizedplacebocontrolledcrossoverstudytoevaluatepostprandialglucometaboliceffectsofmulberryleafextractvitamindchromiumandfiberinpeoplewithtype2diabetes